Prostate-specific membrane antigen is a biomarker for residual disease following neoadjuvant intense androgen deprivation therapy in prostate cancer
John R. Bright(National Cancer Institute), Adam G. Sowalsky(National Cancer Institute)
Cited by 0
Related Papers
No related papers found
Powered by citation graph analysis